Leading science, pioneering therapies
CRM Publications

Highly potent human hematopoietic stem cells first emerge in the intraembryonic aorta-gonad-mesonephros region.

TitleHighly potent human hematopoietic stem cells first emerge in the intraembryonic aorta-gonad-mesonephros region.
Publication TypeJournal Article
Year of Publication2011
AuthorsIvanovs A, Rybtsov S, Welch L, Anderson RA, Turner ML, Medvinsky AL
JournalJ Exp Med
Volume208
Issue12
Pagination2417-27
Date Published2011 Nov 21
ISSN1540-9538
KeywordsAnimals, Aorta, Cell Proliferation, Embryo, Mammalian, Flow Cytometry, Gonads, Hematopoiesis, Hematopoietic Stem Cells, Humans, Mesonephros, Mice, Mice, SCID, Regenerative Medicine
Abstract

Hematopoietic stem cells (HSCs) emerge during embryogenesis and maintain hematopoiesis in the adult organism. Little is known about the embryonic development of human HSCs. We demonstrate that human HSCs emerge first in the aorta-gonad-mesonephros (AGM) region, specifically in the dorsal aorta, and only later appear in the yolk sac, liver, and placenta. AGM region cells transplanted into immunodeficient mice provide long-term high level multilineage hematopoietic repopulation. Human AGM region HSCs, although present in low numbers, exhibit a very high self-renewal potential. A single HSC derived from the AGM region generates at least 300 daughter HSCs in primary recipients, which disseminate throughout the entire recipient bone marrow and are retransplantable. These findings highlight the vast regenerative potential of the earliest human HSCs and set a new standard for in vitro generation of HSCs from pluripotent stem cells for the purpose of regenerative medicine.

DOI10.1084/jem.20111688
Alternate JournalJ. Exp. Med.
PubMed ID22042975
PubMed Central IDPMC3256972
Grant ListG0900962 / / Medical Research Council / United Kingdom
G1002033 / / Medical Research Council / United Kingdom
G1100357 / / Medical Research Council / United Kingdom
/ / Biotechnology and Biological Sciences Research Council / United Kingdom
/ / Medical Research Council / United Kingdom
/ / Wellcome Trust / United Kingdom